Memphis Pharmaceuticals & Chemical Industries (EGX: MPCI)

Market Cap	339.19M
Revenue (ttm)	871.91M
Net Income (ttm)	191.46M
Shares Out	5.63M
EPS (ttm)	34.04
PE Ratio	1.77
Forward PE	n/a
Dividend	2.00 (3.36%)
Ex-Dividend Date	n/a

Volume	590,929
Open	49.61
Previous Close	49.61
Day's Range	48.33 - 59.53
52-Week Range	31.00 - 139.99
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About MPCI

Memphis Pharmaceuticals & Chemical Industries, a drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally. The company offers human health products in various therapeutic areas, including anti-infective, CNS, dermatological, cardio vascular system, corticosteroid, vitamins and minerals, musculo-skeletal system, analgesic and antipyretic, respiratory system, genitourinary system, alimentary tract and metabolism, antihistaminic, antiparasites, and hormones. It also provides animal ...

• Industry: Pharmaceutical Preparations
• Founded: 1940
• Employees: 144
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: MPCI

Financial Performance

In 2024, MPCI's revenue was 871.91 million, an increase of 31.34% compared to the previous year's 663.83 million. Earnings were 191.46 million, an increase of 111.70%.